Carbapenem-resistant Pseudomonas aeruginosa and carbapenem use in Japan: an ecological study

被引:15
作者
Terahara, Fumitaka [1 ]
Nishiura, Hiroshi [1 ,2 ]
机构
[1] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan
[2] Japan Sci & Technol Agcy, CREST, Saitama, Japan
基金
日本学术振兴会; 日本科学技术振兴机构;
关键词
Antibiotic resistance; Pseudomonas aeruginosa; carbapenem; drug prescription; epidemiology; antimicrobial stewardship; RISK-FACTORS; ANTIMICROBIAL RESISTANCE; CONSUMPTION; TRENDS; IMPACT;
D O I
10.1177/0300060519864181
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Objective This study focused on carbapenem resistance in Pseudomonas aeruginosa and examined potential ecological correlations with carbapenem use in Japan. Methods The proportion of carbapenem-resistant P. aeruginosa isolates from 2015 and 2016 by prefecture was obtained from the Japan Nosocomial Infections Surveillance system. Data on carbapenem use was obtained from the National Database of Health Insurance Claims. The correlation between the proportion of carbapenem-resistant isolates and carbapenem consumption was assessed in a cross-sectional manner. The study also collected information on other variables including the numbers of physicians, nurses and medical facilities per 100 000 individuals by prefecture. Results Both the proportion of carbapenem-resistant P. aeruginosa isolates and levels of carbapenem use were higher in western Japan. Using a multivariate model, only carbapenem use remained significantly associated with the proportion of carbapenem-resistant isolates. Conclusions Carbapenem use and the proportion of carbapenem-resistant P. aeruginosa isolates were positively correlated. By longitudinal data collection, this approach offers an avenue to establish causal links as the frequency of carbapenem-resistant P. aeruginosa isolates starts to change in the future.
引用
收藏
页码:4711 / 4722
页数:12
相关论文
共 50 条
  • [41] Virulence Factors Of Carbapenem-Resistant Pseudomonas aeruginosa In Hospital-Acquired Infections In Mansoura, Egypt
    El-Mahdy, Rasha
    El-Kannishy, Ghada
    [J]. INFECTION AND DRUG RESISTANCE, 2019, 12 : 3455 - 3461
  • [42] Molecular characterisation of carbapenem-resistant Pseudomonas aeruginosa clinical isolates in Nepal
    Takahashi, Toshihiro
    Tada, Tatsuya
    Shrestha, Shovita
    Hishinuma, Tomomi
    Sherchan, Jatan B.
    Tohya, Mari
    Kirikae, Teruo
    Sherchand, Jeevan B.
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 26 : 279 - 284
  • [43] Socioeconomic burden of bloodstream infections caused by carbapenem-resistant and carbapenem-susceptible Pseudomonas aeruginosa in China
    Yang, Kai
    Xiao, Tingting
    Shi, Qingyi
    Zhu, Yunying
    Ye, Jing
    Zhou, Yanzi
    Xiao, Yonghong
    [J]. JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 26 : 101 - 107
  • [44] Potency of carbapenems for the prevention of carbapenem-resistant mutants of Pseudomonas aeruginosa -: The high potency of a new carbapenem doripenem
    Sakyo, Shihomi
    Tomita, Haruyoshi
    Tanimoto, Koichi
    Fujimoto, Shuhei
    Ike, Yasuyoshi
    [J]. JOURNAL OF ANTIBIOTICS, 2006, 59 (04) : 220 - 228
  • [45] Evolving landscape of carbapenem-resistant Pseudomonas aeruginosa at a single centre in the USA
    Sakurai, Aki
    Dinh, An Q.
    Hanson, Blake M.
    Shropshire, William C.
    Rizvi, Samie A.
    Rydell, Kirsten
    Tran, Truc T.
    Wanger, Audrey
    Arias, Cesar A.
    Miller, William R.
    [J]. JAC-ANTIMICROBIAL RESISTANCE, 2023, 5 (03):
  • [46] In Vitro Activity of Cefiderocol Against Carbapenem-Resistant Enterobacterales and Pseudomonas aeruginosa
    Malisova, Lucia
    Vrbova, Iveta
    Pomorska, Katarina
    Jakubu, Vladislav
    Zemlickova, Helena
    [J]. MICROBIAL DRUG RESISTANCE, 2023, 29 (10) : 485 - 491
  • [47] Clinical Features and Treatment Outcomes of Carbapenem-Resistant Pseudomonas aeruginosa Keratitis
    Tribin, Felipe Echeverri
    Lieux, Caroline
    Maestre-Mesa, Jorge
    Durkee, Heather
    Krishna, Katherine
    Chou, Brandon
    Neag, Emily
    Tothova, Jana D'Amato
    Martinez, Jaime D.
    Flynn, Harry W.
    Parel, Jean Marie
    Miller, Darlene
    Amescua, Guillermo
    [J]. JAMA OPHTHALMOLOGY, 2024, 142 (05) : 407 - 415
  • [48] Bulgecin A as a β-lactam enhancer for carbapenem-resistant Pseudomonas aeruginosa and carbapenem-resistant Acinetobacter baumannii clinical isolates containing various resistance mechanisms
    Skalweit, Marion J.
    Li, Mei
    [J]. DRUG DESIGN DEVELOPMENT AND THERAPY, 2016, 10 : 3013 - 3020
  • [49] Risk factors and outcome associated with coinfection with carbapenem-resistant Klebsiella pneumoniae and carbapenem-resistant Pseudomonas aeruginosa or Acinetobacter baumanii: a descriptive analysis
    Sophonsri, Anthony
    Kelsom, Corey
    Lou, Mimi
    Nieberg, Paul
    Wong-Beringer, Annie
    [J]. FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [50] Risk factors for mortality in hospitalized patients infected with carbapenem-resistant Pseudomonas aeruginosa in Iran
    Khalili, Younes
    Omidnia, Pooya
    Goli, Hamid Reza
    Zamanlou, Sajjad
    Babaie, Farhad
    Bialvaei, Abed Zahedi
    [J]. GERMS, 2022, 12 (03): : 344 - 351